Biotechnology Jobs

• Belgium-Wavre
• Hybrid
• Director

Provides medical and scientific leadership in pharmacovigilance and risk management for oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and Safety Review Teams, and presents to senior governance committees and regulators. Hybrid role based in the UK, Belgium, Poland or Italy.

• Siena, Italy
• Hybrid
• £81,750 – £136,250 pa
• Director

Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering evidence-based benefit-risk recommendations. Represents Safety on cross-functional clinical matrix teams and governance committees, and may lead Safety Review Teams. The role is hybrid across the UK, Belgium, Poland or Italy, with on-site attendance for key meetings.

• London
• Senior

Leads complex global and multi-regional clinical trials from start-up through close-out, with accountability for quality, timelines, budgets, regulatory compliance and sponsor objectives. Acts as primary strategic partner to sponsors and directs cross-functional teams across regions, with a focus on renal, obesity and MASH studies.

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• US$266,250 – US$443,750 pa
• Director · manages people

Strategically leads global development of an oncology medicine from clinical Proof of Concept to approval in first major markets, acting as single point of accountability. Builds and leads a matrixed Medicine Development Team spanning clinical, medical, commercial and manufacturing, driving evidence packages, governance decisions and lifecycle plans.

• Waltham, United States
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of early clinical development medical directors and clinical scientists, owning Phase I/II clinical development plans including first-in-human, dose-escalation and proof-of-concept studies in lung and head/neck cancers. Bridges preclinical discovery and clinical development, driving translational and biomarker strategy, regulatory submissions and cross-functional matrix teams.

AI/ML

• Stevenage
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of medical directors and clinical scientists designing and executing early-phase oncology trials, including first-in-human, dose-escalation and proof-of-concept studies, while bridging preclinical discovery and clinical development. Accountable for clinical development plans, benefit-risk, regulatory submissions and translational biomarker strategy across lung and head/neck cancer assets.

AI/ML

• Zug, Switzerland
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of early clinical development medical directors and clinical scientists, owning Phase I/II clinical development plans including first-in-human, dose-escalation and proof-of-concept studies in lung and head/neck cancers. Bridges preclinical discovery and clinical development, driving translational and biomarker strategy with cross-functional and regulatory partners.

AI/ML

• London
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of medical directors and clinical scientists designing and executing early-phase oncology trials, including first-in-human and proof-of-concept studies, while bridging preclinical discovery and clinical development. Accountable for clinical development plans, translational and biomarker strategy, and regulatory submissions across a lung and head/neck cancer portfolio.

AI/ML

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of medical directors and clinical scientists designing and executing early-phase oncology trials, including first-in-human and proof-of-concept studies, while bridging preclinical discovery and clinical development. Accountable for clinical development plans, translational and biomarker strategy, and regulatory submissions across lung and head/neck cancer programmes.

AI/ML · Real World Evidence